메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
출처
Springer Science and Business Media LLC The Egyptian Journal of Internal Medicine 37(1)
오류 신고하기
표지

검색

    초록·키워드

    Abstract Background The global burden of chronic kidney disease (CKD) is high, with prevalence being estimated at 8–16%. We aimed to detect the complications of coronavirus disease 2019 (COVID-19) infection in hospitalized CKD and end-stage renal disease (ESRD) patients on regular hemodialysis (HD). Methods A retrospective cohort study was conducted on 450 adult male and female COVID-19 patients aged 18 years or older. Patients were divided according to renal affection into three equal groups: group 1 included patients with normal kidney function tests, group 2 included those with CKD, and group 3 included ESRD patients on regular HD. Data included laboratory tests such as complete blood count (CBC), serum urea, creatinine, C-reactive protein (CRP), D-dimer, coagulation profile, serum ferritin, and liver function tests. Also, electrocardiography (ECG) and echocardiography reports were documented. Results The length of hospital stay and mortality rate were significantly higher in group 3 than in group 1. Gastrointestinal (GIT) events were significantly higher in group 3 than in groups 1 and 2. Renal events were significantly higher in group 2 than in groups 1 and 3, and they were significantly higher in group 1 than in group 3. Conclusions CKD and ESRD patients showed significantly higher mortality due to COVID-19 complications compared to group 1. Acute kidney injury (AKI) and dehydration from severe vomiting and diarrhea were the most noticeable complications among the CKD and ESRD groups. The critical disease was evident among CKD and ESRD groups through significantly prolonged hospital stay and the need for intensive care unit (ICU) admission and ventilation compared to group 1.

    본문·목차

    최근 본 자료 전체보기